Sex differences in Alzheimer’s disease: plasma MMP-9 and markers of disease severity

[1] Govindpani K(2019)Vascular dysfunction in Alzheimer’s disease: a prelude to the pathological process or a consequence of it? J Clin Med 8 651-1032

[2] McNamara LG(2020)Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target Neural Regen Res 15 1030-68

[3] Smith NR(2011)Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer’s disease J Neuroinflammation 8 26-206

[4] Vinnakota C(2020)Apolipoprotein E isoforms differentially regulate matrix metallopeptidase 9 function in Alzheimer’s disease Neurobiol Aging 95 56-24574

[5] Waldvogel HJ(2014)On the structure and functions of gelatinase B/matrix metalloproteinase-9 in neuroinflammation Prog Brain Res 214 193-1507

[6] Faull RL(2006)Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ J Biol Chem 281 24566-511

[7] Govindpani K(2016)Matrix metalloproteinases in the brain and blood–brain barrier: versatile breakers and makers J Cereb Blood Flow Metab 36 1481-216

[8] Vinnakota C(2001)Metalloproteinases in biology and pathology of the nervous system Nat Rev Neurosci 2 502-403

[9] Waldvogel HJ(2009)Matrix metalloproteinases and their multiple roles in neurodegenerative diseases Lancet Neurol 8 205-114

[10] Faull RL(2013)Matrix metalloproteinase-9: many shades of function in cardiovascular disease Physiology. 28 391-355

[1] Govindpani K(2019)Vascular dysfunction in Alzheimer’s disease: a prelude to the pathological process or a consequence of it? J Clin Med 8 651-1032

[2] McNamara LG(2020)Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target Neural Regen Res 15 1030-68

[3] Smith NR(2011)Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer’s disease J Neuroinflammation 8 26-206

[4] Vinnakota C(2020)Apolipoprotein E isoforms differentially regulate matrix metallopeptidase 9 function in Alzheimer’s disease Neurobiol Aging 95 56-24574

[5] Waldvogel HJ(2014)On the structure and functions of gelatinase B/matrix metalloproteinase-9 in neuroinflammation Prog Brain Res 214 193-1507

[6] Faull RL(2006)Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ J Biol Chem 281 24566-511

[7] Govindpani K(2016)Matrix metalloproteinases in the brain and blood–brain barrier: versatile breakers and makers J Cereb Blood Flow Metab 36 1481-216

[8] Vinnakota C(2001)Metalloproteinases in biology and pathology of the nervous system Nat Rev Neurosci 2 502-403

[9] Waldvogel HJ(2009)Matrix metalloproteinases and their multiple roles in neurodegenerative diseases Lancet Neurol 8 205-114

[10] Faull RL(2013)Matrix metalloproteinase-9: many shades of function in cardiovascular disease Physiology. 28 391-355